vs
Ensysce Biosciences, Inc.（ENSC）与Marathon Bancorp, Inc.（MBBC）财务数据对比。点击上方公司名可切换其他公司
Marathon Bancorp, Inc.的季度营收约是Ensysce Biosciences, Inc.的1.2倍（$2.2M vs $1.9M），Marathon Bancorp, Inc.净利率更高（22.3% vs -147.0%，领先169.4%），Ensysce Biosciences, Inc.同比增速更快（44.4% vs 41.7%），过去两年Ensysce Biosciences, Inc.的营收复合增速更高（107.9% vs 20.3%）
Ensysce Biosciences是一家临床阶段生物技术公司，专注于开发疼痛管理和肿瘤适应症领域的创新前药疗法，其专有平台可降低阿片类药物滥用风险并提升治疗有效性，面向全球医疗医药市场，重点解决未被满足的临床需求。
Marathon Bancorp, Inc.是总部位于美国马里兰州的金融控股公司，旗下运营社区银行子公司，面向马里兰州本地个人及中小企业客户提供存款账户、消费贷款、商业抵押贷款、小微企业融资等全品类零售及商业银行服务。
ENSC vs MBBC — 直观对比
营收规模更大
MBBC
是对方的1.2倍
$1.9M
营收增速更快
ENSC
高出2.7%
41.7%
净利率更高
MBBC
高出169.4%
-147.0%
两年增速更快
ENSC
近两年复合增速
20.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.9M | $2.2M |
| 净利润 | $-2.8M | $501.4K |
| 毛利率 | — | — |
| 营业利润率 | -147.8% | 26.2% |
| 净利率 | -147.0% | 22.3% |
| 营收同比 | 44.4% | 41.7% |
| 净利润同比 | 22.3% | 880.7% |
| 每股收益（稀释后） | $-0.51 | $0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENSCMBBC
| Q4 25 | $1.9M | $2.2M | ||
| Q3 25 | $493.1K | $2.1M | ||
| Q2 25 | $1.4M | $1.9M | ||
| Q1 25 | $1.3M | $1.7M | ||
| Q4 24 | $1.3M | $1.6M | ||
| Q3 24 | $3.4M | $1.6M | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $1.6M |
净利润ENSCMBBC
| Q4 25 | $-2.8M | $501.4K | ||
| Q3 25 | $-3.7M | $444.3K | ||
| Q2 25 | $-1.7M | $-332.0K | ||
| Q1 25 | $-1.9M | $148.4K | ||
| Q4 24 | $-3.6M | $51.1K | ||
| Q3 24 | $661.8K | $174.9K | ||
| Q2 24 | — | $85.8K | ||
| Q1 24 | — | $-631.1K |
营业利润率ENSCMBBC
| Q4 25 | -147.8% | 26.2% | ||
| Q3 25 | -758.7% | 25.5% | ||
| Q2 25 | -127.6% | -25.7% | ||
| Q1 25 | -149.1% | 11.6% | ||
| Q4 24 | -274.3% | 3.3% | ||
| Q3 24 | 18.9% | 13.4% | ||
| Q2 24 | — | 4.1% | ||
| Q1 24 | — | -53.7% |
净利率ENSCMBBC
| Q4 25 | -147.0% | 22.3% | ||
| Q3 25 | -756.3% | 20.7% | ||
| Q2 25 | -126.4% | -18.9% | ||
| Q1 25 | -147.4% | 8.9% | ||
| Q4 24 | -273.4% | 3.2% | ||
| Q3 24 | 19.4% | 10.8% | ||
| Q2 24 | — | 6.2% | ||
| Q1 24 | — | -40.7% |
每股收益（稀释后）ENSCMBBC
| Q4 25 | $-0.51 | $0.19 | ||
| Q3 25 | $-1.29 | $0.17 | ||
| Q2 25 | $-0.79 | $-0.13 | ||
| Q1 25 | $-1.39 | $0.07 | ||
| Q4 24 | $-0.89 | $0.02 | ||
| Q3 24 | $1.00 | $0.06 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.2M | $46.9M |
| 总资产 | $7.5M | $248.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ENSCMBBC
| Q4 25 | $4.3M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $3.1M | — | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $4.2M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ENSCMBBC
| Q4 25 | $3.2M | $46.9M | ||
| Q3 25 | $1.2M | $46.3M | ||
| Q2 25 | $3.4M | $45.7M | ||
| Q1 25 | $3.0M | $32.0M | ||
| Q4 24 | $3.7M | $31.7M | ||
| Q3 24 | $6.9M | $31.6M | ||
| Q2 24 | — | $31.3M | ||
| Q1 24 | — | $31.4M |
总资产ENSCMBBC
| Q4 25 | $7.5M | $248.0M | ||
| Q3 25 | $3.2M | $246.0M | ||
| Q2 25 | $5.6M | $238.8M | ||
| Q1 25 | $4.6M | $236.8M | ||
| Q4 24 | $5.6M | $217.9M | ||
| Q3 24 | $9.4M | $216.5M | ||
| Q2 24 | — | $219.3M | ||
| Q1 24 | — | $225.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $1.4M |
| 自由现金流经营现金流 - 资本支出 | — | $1.4M |
| 自由现金流率自由现金流/营收 | — | 62.3% |
| 资本支出强度资本支出/营收 | — | 0.6% |
| 现金转化率经营现金流/净利润 | — | 2.82× |
| 过去12个月自由现金流最近4个季度 | — | $3.9M |
8季度趋势，按日历期对齐
经营现金流ENSCMBBC
| Q4 25 | $-1.5M | $1.4M | ||
| Q3 25 | $-1.9M | $464.0K | ||
| Q2 25 | $-2.7M | $1.4M | ||
| Q1 25 | $-1.7M | $849.0K | ||
| Q4 24 | $-764.1K | $113.6K | ||
| Q3 24 | $-1.0M | $945.2K | ||
| Q2 24 | — | $416.6K | ||
| Q1 24 | — | $-802.1K |
自由现金流ENSCMBBC
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $456.6K | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | — | $773.2K | ||
| Q4 24 | — | $105.0K | ||
| Q3 24 | — | $921.6K | ||
| Q2 24 | — | $-1.8M | ||
| Q1 24 | — | $-1.1M |
自由现金流率ENSCMBBC
| Q4 25 | — | 62.3% | ||
| Q3 25 | — | 21.3% | ||
| Q2 25 | — | 66.0% | ||
| Q1 25 | — | 46.3% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | — | 57.1% | ||
| Q2 24 | — | -118.5% | ||
| Q1 24 | — | -67.9% |
资本支出强度ENSCMBBC
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 145.2% | ||
| Q1 24 | — | 16.2% |
现金转化率ENSCMBBC
| Q4 25 | — | 2.82× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.72× | ||
| Q4 24 | — | 2.22× | ||
| Q3 24 | -1.54× | 5.40× | ||
| Q2 24 | — | 4.85× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
